Sacituzumab govitecan
Product Specifications
CAS Number
1491917-83-9
Target
Antibody-Drug Conjugates (ADCs), TROP2
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
0.984
Bioactivity
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-ADRb2-Ra-01 96 Tests
Rat Adrenergic Receptor Beta 2 (ADRb2) ELISA Kit
Sign In for Pricing
View Details RD-ADRb2-Ra-02 48 Tests
Rat Adrenergic Receptor Beta 2 (ADRb2) ELISA Kit
Sign In for Pricing
View Details 